Pancreatic cancer is four diseases, each with new treatment possibilities

February 24, 2016, University of Melbourne
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain

An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.

The significant findings also include 10 genetic pathways at the core of transforming normal tissue into cancerous tumours. Some of these processes are related to bladder and lung cancers, opening up the possibility of using treatments for these cancers to also treat pancreatic cancer.

The study was led by Prof Sean Grimmond, formerly of The University of Queensland's Institute for Molecular Bioscience (IMB), now the Director of Research & The Bertalli Chair in Cancer Medicine, University of Melbourne Centre for Cancer Research.

Published today in the international journal Nature, the research team included Professor Andrew Biankin from the Garvan Institute of Medical Research and the University of New South Wales and bioinformatician Dr Nicola Waddell, now based at QIMR Berghofer Medical Research.

Over seven years, scientists analysed the genomes of 456 pancreatic tumours to determine the core processes that are damaged when normal pancreatic tissues change into aggressive cancers.

Professor Grimmond said there was an urgent need for more knowledge about the genetic causes of pancreatic cancer, with most patients only living a few months after diagnosis and the condition predicted to become the second most common cancer in Western countries within a decade.

"We identified 32 genes from 10 that are consistently mutated in pancreatic tumours, but further analysis of gene activity revealed four distinct subtypes of tumours," Professor Grimmond said.

"This study demonstrates that pancreatic cancer is better considered as four separate diseases, with different , treatments and underlying genetics.

"Knowing which subtype a patient has would allow a doctor to provide a more accurate prognosis and treatment recommendations.

Importantly Professor Grimmond said there are already cancer drugs, and drugs in development, that can potentially target the parts of the 'damaged machinery' driving pancreatic cancers to start.

For example some strains of pancreatic cancer are unexpectedly associated with mutations normally associated with colon cancer or leukaemia and for which experimental drugs are available or in development. Other pancreatic cancers bear strong similarities to some bladder and lung cancers and we can start to draw on that knowledge to improve treatments," he says.

In a world first, the team performed an integrated genomic analysis, meaning they combined the results of several techniques to examine not only the genetic code, but also variations in structure and gene activity, revealing more information than ever before about the damage that leads to .

This study builds on earlier studies performed by the team as part of the International Cancer Genome Consortium (ICGC).

Explore further: Pancreatic cancer has four distinct types

More information: Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, DOI: 10.1038/nature16965

Related Stories

Pancreatic cancer has four distinct types

February 27, 2015
Researchers have found that pancreatic cancer can be split into four unique types, a discovery that could be used to improve treatments for the disease, according to a study published in Nature.

Plant extract shows promise in treating pancreatic cancer

February 11, 2016
A natural extract derived from India's neem tree could potentially be used to treat pancreatic cancer, according to a new study in the journal Scientific Reports.

Unmasking the deadly secrets of pancreatic cancer

October 25, 2012
(Medical Xpress)—A large-scale study that defines the complexity of underlying mutations responsible for pancreatic cancers in more than 100 patients was published in Nature.

Genomic sequence reveals new treatment options for pancreatic cancer

February 27, 2015
An international project assisted by researchers from The University of Western Australia has offered new hope to patients with pancreatic cancer.

Body's cancer defences hijacked to make pancreatic and lung cancers more aggressive

April 2, 2015
Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive, according to research published in Cancer Cell ...

Diabetes drug found not to cause pancreatic cancer

February 23, 2016
The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ). The ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

Overcoming resistance to a standard chemotherapy drug

July 19, 2018
Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.